NCT07080528View on ClinicalTrials.gov

Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 6, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions
Neuromuscular Blocking AgentsResidual Neuromuscular BlockNeuromuscular Blockade Monitoring
Interventions
DRUG

Sevofluorane

Investigation of the effect of Sevoflurane on muscle relaxation

DRUG

Propofol

Investigation of the effect of Propofol on muscle relaxation

Trial Locations (1)

4032

University of Debrecen, Department of Anesthesiology and Intensive Care, Debrecen

All Listed Sponsors
lead

Tamas Vegh, MD

OTHER